Insider · CIK 0002067692
Gregory M Milosevich
Files at DHR (DANAHER CORP /DE/). First filing Feb 20, 2026, latest Feb 20, 2026.
In brief
Gregory M Milosevich files SEC Form 4 as officer at DHR (DANAHER CORP /DE/). Since Feb 20, 2026, Gregory M Milosevich has reported 0 open-market buys worth $0 and 1 open-market sell worth $275k, the latest filed on Feb 20, 2026.
A track record needs three past buys with six months of prices behind them; Gregory M Milosevich has 0, so none is measured yet.
The newest scored trade: sold $275k of DHR on Feb 19, 2026, filed Feb 20, 2026, scored 18 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $275k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DHR: DANAHER CORP /DE/
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | DHRsell DANAHER CORP /DE/ | $275k 1,320 shares | -21% | +22% from low-13% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 19, 2026 | DHR DANAHER CORP /DE/ | 1,320 0.00% of outstanding | $275k | Feb 19, 2026 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | DHR DANAHER CORP /DE/ | AGrant or award Common Stock | +15,402 | $0.00 | $0 | 24,467 | Aug 6, 2026 |
| Mar 1, 2026 | DHR DANAHER CORP /DE/ | AGrant or award Common Stock | +4,273 | $0.00 | $0 | 9,183 | Mar 3, 2026 |
| Mar 1, 2026 | DHR DANAHER CORP /DE/ | FTax withholding Common Stock | -118 | $210.64 | $25k | 9,065 | Mar 3, 2026 |
| Mar 1, 2026 | DHR DANAHER CORP /DE/ | AGrant or award Employee stock option (right to buy)derivative | +11,548 | $0.00 | $0 | 11,548 | Mar 3, 2026 |
| Feb 24, 2026 | DHR DANAHER CORP /DE/ | FTax withholding Common Stock | -189 | $209.19 | $40k | 4,910 | Feb 25, 2026 |
| Feb 19, 2026 | DHR DANAHER CORP /DE/ | MOption exercise Common Stock | +1,320 | $58.59 | $77k | 6,419 | Feb 20, 2026 |
| Feb 19, 2026 | DHR DANAHER CORP /DE/ | SOpen-market sale Common Stock | -1,320 | $208.01 | $275k | 5,099 | Feb 20, 2026 |
| Feb 19, 2026 | DHR DANAHER CORP /DE/ | MOption exercise Employee stock option (right to buy)derivative | -1,320 | $0.00 | $0 | 0 | Feb 20, 2026 |
| Feb 4, 2026 | DHR DANAHER CORP /DE/ | AGrant or award Common Stock | +679 | $0.00 | $0 | 5,099 | Feb 6, 2026 |
| Feb 2, 2026 | DHR DANAHER CORP /DE/ | AGrant or award Danaher Deferred Compensation Programs - Danaher Stock Fundderivative | +629 | $228.92 | $144k | 5,031 | Feb 4, 2026 |
| Nov 15, 2025 | DHR DANAHER CORP /DE/ | FTax withholding Common Stock | -35 | $221.21 | $7,742 | 4,420 | Nov 18, 2025 |
Questions about Gregory M Milosevich
Answered from the filings on this page, as of the latest one.
Is Gregory M Milosevich buying or selling?
In the last 12 months Gregory M Milosevich reported 0 open-market buys worth $0 and 1 open-market sell worth $275k on SEC Form 4; the latest was sold $275k of DHR on Feb 19, 2026. Grants, option exercises and tax withholding are not counted.
How did Gregory M Milosevich's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gregory M Milosevich has 0.
Where does Gregory M Milosevich file Form 4?
Gregory M Milosevich has filed Form 4 at DHR (DANAHER CORP /DE/) as Executive Vice President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.